From the Desk of Editor-in-Chief
[Year:2016] [Month:October-December] [Volume:2] [Number:4] [Pages:1] [Pages No:0 - 0]
DOI: 10.5005/htnj-2-4-iv | Open Access | How to cite |
Current Use of Diuretics in the Management of Hypertension
[Year:2016] [Month:October-December] [Volume:2] [Number:4] [Pages:2] [Pages No:181 - 182]
DOI: 10.5005/jp-journals-10043-0052 | Open Access | How to cite |
Abstract
Chobanian AV. Current Use of Diuretics in the Management of Hypertension. Hypertens J 2016;2(4):181-182.
[Year:2016] [Month:October-December] [Volume:2] [Number:4] [Pages:6] [Pages No:183 - 188]
DOI: 10.5005/jp-journals-10043-0053 | Open Access | How to cite |
Abstract
Weber MA. Will the Systolic Blood Pressure Intervention Trial (SPRINT) change Treatment Targets in Hypertension? Hypertens J 2016;2(4):183-188.
Heart Rate as a Marker of Cardiovascular Prognosis
[Year:2016] [Month:October-December] [Volume:2] [Number:4] [Pages:5] [Pages No:189 - 193]
DOI: 10.5005/jp-journals-10043-0054 | Open Access | How to cite |
Abstract
Seravalle G, Grassi G. Heart Rate as a Marker of Cardiovascular Prognosis. Hypertens J 2016;2(4):189-193.
[Year:2016] [Month:October-December] [Volume:2] [Number:4] [Pages:6] [Pages No:194 - 199]
DOI: 10.5005/jp-journals-10043-0055 | Open Access | How to cite |
Abstract
Deedwania P, Acharya T. Clinical Implications of Recent Therapeutic Trials in Hypertension: Insights from SPRINT and HOPE-3 Trials. Hypertens J 2016;2(4):194-199.
[Year:2016] [Month:October-December] [Volume:2] [Number:4] [Pages:9] [Pages No:200 - 208]
DOI: 10.5005/jp-journals-10043-0056 | Open Access | How to cite |
Abstract
Pareek A, Abhyankar M, Ghag S. Renaissance of Chlorthalidone. Hypertens J 2016;2(4):200-208.
The Chlorthalidone Saga: How the US Medical Community was mislead in Past?
[Year:2016] [Month:October-December] [Volume:2] [Number:4] [Pages:2] [Pages No:209 - 210]
DOI: 10.5005/jp-journals-10043-0057 | Open Access | How to cite |
Abstract
Messerli FH. The Chlorthalidone Saga: How the US Medical Community was mislead in Past? Hypertens J 2016;2(4):209-210.
Autonomic Neuromodulation through Devices for Hypertension
[Year:2016] [Month:October-December] [Volume:2] [Number:4] [Pages:8] [Pages No:211 - 218]
DOI: 10.5005/jp-journals-10043-0058 | Open Access | How to cite |
Abstract
Pathak A, Honton B, Fondard O, Dumonteil N, Tchetche D, Fajadet J. Autonomic Neuromodulation through Devices for Hypertension. Hypertens J 2016;2(4):211-218.
Hypertension Capsule—Cardiological Society of India 2016: Swallow It!
[Year:2016] [Month:October-December] [Volume:2] [Number:4] [Pages:2] [Pages No:219 - 220]
DOI: 10.5005/jp-journals-10043-0059 | Open Access | How to cite |
Abstract
Nair T. Hypertension Capsule— Cardiological Society of India 2016: Swallow It! Hypertens J 2016;2(4):219-220.
Systolic and Diastolic Blood Pressure: Do We add or subtract to estimate the Blood Pressure Burden?
[Year:2016] [Month:October-December] [Volume:2] [Number:4] [Pages:4] [Pages No:221 - 224]
DOI: 10.5005/jp-journals-10043-0060 | Open Access | How to cite |
Abstract
Nair T. Systolic and Diastolic Blood Pressure: Do We add or subtract to estimate the Blood Pressure Burden? Hypertens J 2016;2(4):221-224.
[Year:2016] [Month:October-December] [Volume:2] [Number:4] [Pages:2] [Pages No:225 - 226]
DOI: 10.5005/jp-journals-10043-0061 | Open Access | How to cite |
Abstract
Rao KS. Pheochromocytoma. Hypertens J 2016;2(4):225-226.